SECreport

Form 4 INOVIO PHARMACEUTICALS, For: May 21 Filed by: BENITO SIMON X

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx